Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Qian Jiang,Zongru Li,Gongli Zhang,Yu Hu,Weiming Li,Yongping Song,Junmin Li,Li Zhou,Bingcheng Liu,Xiaoli Liu,Na Xu,Suning Chen,Zhenfang Liu,Huanling Zhu,Jie Jin,He Huang,Sixuan Qian,Li Meng,Xin Du,Xielan Zhao, Sujun Gao, Yang Liang, Ming Hou, Wei Wang, Zi Chen, Qian Niu, Lichuang Men, Dajun Yang, Yifan Zhai, Xiaojun Huang

BLOOD(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要